- Arcadia Biosciences Inc (NASDAQ:RKDA) reported fourth-quarter revenue declined 70% year-over-year to $2.17 million, missing the consensus of $3.33 million.
- Net loss was $(9.3) million of $(0.42) per share, compared to the $8.9 million of income recognized in 4Q20, missing the consensus of $(0.30).
- RKDA reported a loss from operations of $(13.04) million for the quarter, compared to an income of $7.46 million a year ago.
- Net cash used in operating activities for FY21 totaled $25.87 million, compared to $30.22 million in FY20.
- Arcadia Biosciences held cash and cash equivalents of $28.68 million as of December 31, 2021.
- RKDA shares have gained about 60.2% year-to-date
- Price Action: RKDA shares are trading lower by 30.20% at $1.32 during the post-market session on Wednesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Arcadia Biosciences Shares Plunge Afterhours As Q4 Earnings Miss Estimates
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks